化合物简介
LY-272,015 is a beta-carboline derivative drug developed by Eli Lilly, which acts as a potent and selective antagonist at the serotonin 5-HT2B receptor. It has anti-hypertensive effects in animal models, and is also used in research into the other functions of the 5-HT2B receptor.
基本信息
中文名称
1-(3,4-二甲氧基苄基)-6-甲基-2,3,4,9-四氢-1H-吡啶并[3,4-B]吲哚盐酸盐
英文名称
1-[(3,4-dimethoxyphenyl)methyl]-6-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole
中文别名
英文别名
LY-272,015
CAS号
172895-15-7
分子式
C21H25ClN2O2
分子量
372.888
精确质量
372.16
PSA
46.28
LOGP
5.0538
